Amgen's Sjögren's treatment succeeds in late-stage trial
AMGN
Statements (3)
- Neutral
Amgen is offering first effective therapy for Sjögren's patients
- Bullish
Amgen published promising results for its experimental Sjogren's treatment
- Bullish
Amgen's autoimmune drug succeeded in late-stage trial